Imunon (IMNN) Total Liabilities (2010 - 2026)
Imunon's (IMNN) quarterly Total Liabilities came in at $4.7 million in Q1 2026, down 27.32% YoY from $6.4 million in Q1 2025, and down 10.85% on a QoQ basis from $5.2 million in Q4 2025.
Imunon (IMNN) Total Liabilities (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Total Liabilities data on file, last reported at $4.7 million in Q1 2026.
- Quarterly Total Liabilities fell 27.32% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 27.32% YoY) and the FY2025 annual result came in at $5.2 million, down 4.51% from the prior year.
- Total Liabilities retreated to $4.7 million in Q1 2026, from $5.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $19.2 million in Q3 2022 to a low of $4.7 million in Q1 2026.
- A 5-year average of $9.5 million and a median of $6.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities plunged 65.68% — and 2025, when it increased 10.04%.
- Tracing IMNN's Total Liabilities over 5 years: stood at $14.6 million in 2022, then plunged by 41.76% to $8.5 million in 2023, then tumbled by 35.84% to $5.5 million in 2024, then fell by 4.51% to $5.2 million in 2025, then declined by 10.85% to $4.7 million in 2026.
- The last three Total Liabilities figures came in at $4.7 million (Q1 2026), $5.2 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 10.03 Bn |
| 10 | Imunon | 8.58 Mn | 8.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.66 Mn |
| Dec 31, 2025 | 5.23 Mn |
| Sep 30, 2025 | 4.91 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.41 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | 5.83 Mn |
| Dec 31, 2023 | 8.53 Mn |
| Sep 30, 2023 | 6.58 Mn |
| Jun 30, 2023 | 7.21 Mn |
| Mar 31, 2023 | 15.46 Mn |
| Dec 31, 2022 | 14.65 Mn |
| Sep 30, 2022 | 19.18 Mn |
| Jun 30, 2022 | 18.29 Mn |
| Mar 31, 2022 | 18.08 Mn |
| Dec 31, 2021 | 18.25 Mn |
| Sep 30, 2021 | 20.13 Mn |
| Jun 30, 2021 | 18.96 Mn |
| Mar 31, 2021 | 18.08 Mn |